Wednesday, February 20, 2013

• Upcoming Catalysts For These BioPharmas Provide Potential Upsideat Seeking Alpha (Wed, Feb 20)

Tuesday, February 19, 2013

• Big Growth Stories in Biotechat Motley Fool (Tue, Feb 19)

Thursday, February 14, 2013

• Ram Selvaraju: Fall In Love With These Biotech Stocksat Seeking Alpha (Thu, Feb 14)

Tuesday, February 12, 2013

• Time To Dump Diluted Shares Of Trius - Or Double Down?at Seeking Alpha (Tue, Feb 12)

Monday, February 4, 2013

• Trius Therapeutics: Takeover Candidate In 2013at Seeking Alpha (Mon, Feb 4)

Wednesday, January 30, 2013

• 5 Biotech Stocks Under $10 Moving Higherat TheStreet (Wed, Jan 30)

Wednesday, January 23, 2013

• Why The Trius Offering Is A Positive Moveat Seeking Alpha (Wed, Jan 23)

Monday, January 21, 2013

• Trius: Why Last Friday's Equity Offering Is Good For The Stockat Seeking Alpha (Mon, Jan 21)

Friday, January 18, 2013

• Trius Investors: Hit With Dilutionat Motley Fool (Fri, Jan 18)
• TRIUS THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibEDGAR Online (Fri, Jan 18)
• The Momentum Of Trius Therapeuticsat Seeking Alpha (Fri, Jan 18)

Monday, January 14, 2013

• Trius: In An About Face, Congress Is Helping Biotech Companies That Are Developing Antibioticsat Seeking Alpha (Mon, Jan 14)

Thursday, January 10, 2013

• The Impact Of Off-Label Use Of Zyvox And Its Import For Trius And Tedizolidat Seeking Alpha (Thu, Jan 10)

Tuesday, January 8, 2013

• Cubist Pharmaceuticals Deal Seen Sales Ticket: Real M&Aat Bloomberg (Tue, Jan 8)

Monday, January 7, 2013

• Trius Quickens Pace Towards Commercialization With FDA Designation For Tedizolid Phosphateat Seeking Alpha (Mon, Jan 7)
• TRIUS THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial StaEDGAR Online (Mon, Jan 7)

Friday, December 28, 2012

• End Of The Year Shopping Spree Should Have Trius On The Listat Seeking Alpha (Fri, Dec 28)

Thursday, December 20, 2012

• Resistance (To Resistance) Is Futile: The Growing Opportunity For Trius And Tedizolidat Seeking Alpha (Thu, Dec 20)

Tuesday, December 18, 2012

• Bear Thesis On Trius Therapeutics Seems Flawedat Seeking Alpha (Tue, Dec 18)

Wednesday, December 12, 2012

• TRIUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Wed, Dec 12)

Tuesday, December 11, 2012

• Trius: The Winner In The War Against MRSAat Seeking Alpha (Tue, Dec 11)
• 3 Stocks Near 52-Week Lows Worth Buyingat Motley Fool (Tue, Dec 11)

Thursday, December 6, 2012

• Trius Therapeutics: A Long, Stable, And Steady Playat Seeking Alpha (Thu, Dec 6)

Wednesday, December 5, 2012

• The Worst of 2012: Trius Therapeuticsat Motley Fool (Wed, Dec 5)
• Trius Therapeutics: Tedizolid's Potential Commercial Pathsat Seeking Alpha (Wed, Dec 5)

Add TSRX News to My Yahoo!